David Twesigomwe to Pharmacogenetics
This is a "connection" page, showing publications David Twesigomwe has written about Pharmacogenetics.
Connection Strength
2,731
-
Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub-Saharan African Populations. Clin Pharmacol Ther. 2024 03; 115(3):576-594.
Score: 0,879
-
Characterization of CYP2D6 Pharmacogenetic Variation in Sub-Saharan African Populations. Clin Pharmacol Ther. 2023 03; 113(3):643-659.
Score: 0,811
-
Characterization of NAT, GST, and CYP2E1 Genetic Variation in Sub-Saharan African Populations: Implications for Treatment of Tuberculosis and Other Diseases. Clin Pharmacol Ther. 2025 May; 117(5):1338-1357.
Score: 0,237
-
Characterization of CYP2C19 pharmacogenetic variation in African populations and comparison with other global populations. Pharmacogenomics. 2023 Nov; 24(16):845-857.
Score: 0,218
-
Promoting Pharmacogenomics in Africa: Perspectives From Variation in G6PD and Other Pharmacogenes. Clin Pharmacol Ther. 2023 03; 113(3):476-479.
Score: 0,205
-
Characterization of POR haplotype distribution in African populations and comparison with other global populations. Pharmacogenomics. 2022 09; 23(14):771-782.
Score: 0,201
-
StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes. Clin Pharmacol Ther. 2021 09; 110(3):741-749.
Score: 0,181